Dianthus Therapeutics, Inc.DNTHNASDAQ
Loading
Cash & Equivalents Over TimeStable
Percentile Rank33
3Y CAGR+49.3%
5Y CAGR-2.6%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+49.3%/yr
vs -28.4%/yr prior
5Y CAGR
-2.6%/yr
Recent acceleration
Acceleration
+77.6pp
Accelerating
Percentile
P33
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $51.09M | +124.1% |
| 2024 | $22.79M | -82.8% |
| 2023 | $132.32M | +761.2% |
| 2022 | $15.37M | -88.3% |
| 2021 | $131.65M | +126.4% |
| 2020 | $58.15M | -10.6% |
| 2019 | $65.07M | +11.5% |
| 2018 | $58.34M | +13.1% |
| 2017 | $51.57M | +1035.1% |
| 2016 | $4.54M | - |